MetLife Investment Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
|
|||||
|
2025
Q1 | $153K | Hold |
|
|||||
|
2024
Q4 | $198K | Buy |
|
|||||
|
2024
Q3 | $344K | Buy |
|
|||||
|
2024
Q2 | $188K | Buy |
|
|||||
|
2024
Q1 | $175K | Hold |
|
|||||
|
2023
Q4 | $150K | Hold |
|
|||||
|
2023
Q3 | $171K | Buy |
|
|||||
|
2023
Q2 | $176K | Hold |
|
|||||
|
2023
Q1 | $87.8K | Hold |
|
|||||
|
2022
Q4 | $138K | Hold |
|
|||||
|
2022
Q3 | $136K | Hold |
|
|||||
|
2022
Q2 | $104K | Hold |
|
|||||
|
2022
Q1 | $167K | Buy |
|
|||||
|
2021
Q4 | $153K | Hold |
|
|||||
|
2021
Q3 | $249K | Hold |
|
|||||
|
2021
Q2 | $263K | Buy |
|
|||||
|
2021
Q1 | $191K | Hold |
|
|||||
|
2020
Q4 | $169K | Hold |
|
|||||
|
2020
Q3 | $187K | Hold |
|
|||||
|
2020
Q2 | $167K | Hold |
|
|||||
|
2020
Q1 | $131K | Buy |
|